Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO)

Diffuse large B-cell lymphoma patients have a 5% overall risk of central nervous system events (relapse or progression), which account for high morbidity and frequently fatal outcomes, and shortened overall survival of

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haematologica (Roma) 2017-02, Vol.102 (2), p.235-245
Hauptverfasser:	Peñalver, Francisco-Javier, Sancho, Juan-Manuel, de la Fuente, Adolfo, Olave, María-Teresa, Martín, Alejandro, Panizo, Carlos, Pérez, Elena, Salar, Antonio, Orfao, Alberto
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Biopsy Central Nervous System Neoplasms - diagnosis Central Nervous System Neoplasms - prevention & control Central Nervous System Neoplasms - secondary Central Nervous System Neoplasms - therapy Chemoprevention Combined Modality Therapy Disease Management Guideline Humans Immunophenotyping Lymphoma, Large B-Cell, Diffuse - pathology Multimodal Imaging Risk Factors Spain
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Diffuse large B-cell lymphoma patients have a 5% overall risk of central nervous system events (relapse or progression), which account for high morbidity and frequently fatal outcomes, and shortened overall survival of
ISSN:	0390-6078 1592-8721
DOI:	10.3324/haematol.2016.149120